Endoscopic Ultrasound-Directed Transgastric ERCP (EDGE) Utilization of Trends Among Interventional Endoscopists.
EDGE
Endoscopic ultrasound-directed transgastric ERCP
Laparoscopy-assisted ERCP
Pancreaticobiliary
Roux-en-Y gastric bypass
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
19
05
2022
accepted:
29
07
2022
medline:
17
4
2023
pubmed:
11
8
2022
entrez:
10
8
2022
Statut:
ppublish
Résumé
Endoscopic ultrasound-directed transgastric ERCP (EDGE) has become standard-of-care therapy at many centers for pancreaticobiliary disease in patients with Roux-en-Y Gastric Bypass. In this study, we aimed to evaluate the opinions and practices of endoscopists who perform EDGE. A 22-question utilization of EDGE survey was sent to 36 advanced endoscopists at tertiary care centers in the United States. The two-section survey included questions regarding advanced endoscopy volume and training at the respective facilities, and questions on specific details of EDGE utilization. Among 36 interventional endoscopists (IE) surveyed, 14 (39%) reported performing > 1000 ERCPs annually. Thirty (83%) offered EDGE as an option for Roux-en-Y gastric bypass patients with previous cholecystectomy. Other options offered included: 19 (53%) offered Laparoscopy-assisted ERCP (LA-ERCP), 7 (19%) offered Single-Balloon ERCP (SBE), and 10 (28%) offered percutaneous drainage (PTC). Twenty (56%) IE performed 10 or less EDGE procedures, while 16 (44%) performed 11 or more. Single-session EDGE was performed by 7 (19%) IE, while 15 (42%) performed dual session, and 13 (36%) performed both. 19 (53%) actively closed fistulas while 17 (47%) let them close spontaneously. Thirty one (86%) reported a technical success rate of 91% to 100%. The most frequently reported immediate adverse event post-procedurally was abdominal pain, reported by 17 IE (47%). Weight gain was reported by 2 IE (6%). EDGE continues to gain in popularity as an option for Roux-en-Y gastric bypass patients requiring pancreaticobiliary interventions, with 24/36 IE (67%) believing that it should be the new standard. In addition, most report a low frequency of post-procedural weight gain. ClinicalTrials.gov Identifier NCT05041608.
Sections du résumé
BACKGROUND
Endoscopic ultrasound-directed transgastric ERCP (EDGE) has become standard-of-care therapy at many centers for pancreaticobiliary disease in patients with Roux-en-Y Gastric Bypass. In this study, we aimed to evaluate the opinions and practices of endoscopists who perform EDGE.
METHODS
A 22-question utilization of EDGE survey was sent to 36 advanced endoscopists at tertiary care centers in the United States. The two-section survey included questions regarding advanced endoscopy volume and training at the respective facilities, and questions on specific details of EDGE utilization.
RESULTS
Among 36 interventional endoscopists (IE) surveyed, 14 (39%) reported performing > 1000 ERCPs annually. Thirty (83%) offered EDGE as an option for Roux-en-Y gastric bypass patients with previous cholecystectomy. Other options offered included: 19 (53%) offered Laparoscopy-assisted ERCP (LA-ERCP), 7 (19%) offered Single-Balloon ERCP (SBE), and 10 (28%) offered percutaneous drainage (PTC). Twenty (56%) IE performed 10 or less EDGE procedures, while 16 (44%) performed 11 or more. Single-session EDGE was performed by 7 (19%) IE, while 15 (42%) performed dual session, and 13 (36%) performed both. 19 (53%) actively closed fistulas while 17 (47%) let them close spontaneously. Thirty one (86%) reported a technical success rate of 91% to 100%. The most frequently reported immediate adverse event post-procedurally was abdominal pain, reported by 17 IE (47%). Weight gain was reported by 2 IE (6%).
CONCLUSION
EDGE continues to gain in popularity as an option for Roux-en-Y gastric bypass patients requiring pancreaticobiliary interventions, with 24/36 IE (67%) believing that it should be the new standard. In addition, most report a low frequency of post-procedural weight gain.
CLINICAL TRIAL REGISTRATION
ClinicalTrials.gov Identifier NCT05041608.
Identifiants
pubmed: 35947304
doi: 10.1007/s10620-022-07650-1
pii: 10.1007/s10620-022-07650-1
doi:
Banques de données
ClinicalTrials.gov
['NCT05041608']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1167-1177Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Kedia P, Sharaiha RZ, Kumta NA, Kahaleh M. Internal EUS-directed transgastric ERCP (EDGE): game over. Gastroenterology. 2014;147:566–568.
doi: 10.1053/j.gastro.2014.05.045
pubmed: 24975458
Tyberg A, Nieto J, Salgado S, Weaver K, Kedia P, Sharaiha RZ et al. Endoscopic ultrasound (EUS)-directed transgastric endoscopic retrograde cholangiopancreatography or EUS: mid-term analysis of an emerging procedure. Clin Endosc. 2017;50:185–190.
doi: 10.5946/ce.2016.030
pubmed: 27642849
Ngamruengphong S, Nieto J, Kunda R, Kumbhari V, Chen YI, Bukhari M et al. Endoscopic ultrasound-guided creation of a transgastric fistula for the management of hepatobiliary disease in patients with Roux-en-Y gastric bypass. Endoscopy. 2017;49:549–552.
doi: 10.1055/s-0043-105072
pubmed: 28395382
Kedia P, Tarnasky PR, Nieto J, Steele SL, Siddiqui A, Xu MM et al. EUS-directed transgastric ERCP (EDGE) versus laparoscopy-assisted ERCP (LA-ERCP) for Roux-en-Y Gastric Bypass (RYGB) anatomy: a multicenter early comparative experience of clinical outcomes. J Clin Gastroenterol. 2019;53:304–308.
doi: 10.1097/MCG.0000000000001037
pubmed: 29668560
Hsueh W, Krafft MR, Abdelqader A, Nasr J. Su1167 EUS-directed transgastric ercp with 20 mm lumen-apposing metal stents in patients with Roux-EN-Y gastric bypass, are we closer to perfection? Gastrointest Endosc. 2019;89:297.
doi: 10.1016/j.gie.2019.03.1188
James TW, Baron TH. Endoscopic ultrasound-directed transgastric ERCP (EDGE): a single-center US experience with follow-up data on fistula closure. Obes Surg. 2019;29:451–456.
doi: 10.1007/s11695-018-3531-2
pubmed: 30302653
pmcid: 6550479
Wang TJ, Thompson CC, Ryou M. Gastric access temporary for endoscopy (GATE): a proposed algorithm for EUS-directed transgastric ERCP in gastric bypass patients. Surg Endosc. 2019;33:2024–2033.
doi: 10.1007/s00464-019-06715-z
pubmed: 30805786
Chiang AL, Gaidhane M, Loren DE, Kahaleh M, Schlachterman A, Millman J et al. 338 Impact of EUS-Directed Transgastric ERCP (edge procedure) access route on technical success and adverse events: a multi-center experience. Gastrointest Endosc 2018;87:70–71.
doi: 10.1016/j.gie.2018.04.058
Runge TM, Kowalski TE, Baron TH, Chiang AL, James T, Schlachterman A et al. 1026 Living on the edge - success, long-term complications, and implications following EUS-directed transgastric ERCP: a multicenter study. Gastrointest Endosc 2019;89:131.
doi: 10.1016/j.gie.2019.04.165
Krafft MR, Hsueh W, James TW, Runge TM, Baron TH, Khashab MA et al. The EDGI new take on EDGE: EUS-directed transgastric intervention (EDGI), other than ERCP, for Roux-en-Y gastric bypass anatomy: a multicenter study. Endosc Int Open. 2019;7:E1231–E1240.
doi: 10.1055/a-0915-2192
pubmed: 31579704
pmcid: 6773567
Runge TM, Chiang AL, Kowalski TE, James TW, Baron TH, Nieto J et al. Endoscopic ultrasound-directed transgastric ERCP (EDGE): a retrospective multicenter study. Endoscopy 2021;53:611–618.
doi: 10.1055/a-1254-3942
pubmed: 32882722
Bukhari M, Kowalski T, Nieto J, Kunda R, Ahuja NK, Irani S et al. An international, multicenter, comparative trial of EUS-guided gastrogastrostomy-assisted ERCP versus enteroscopy-assisted ERCP in patients with Roux-en-Y gastric bypass anatomy. Gastrointest Endosc. 2018;88:486–494.
doi: 10.1016/j.gie.2018.04.2356
pubmed: 29730228
Keswani RN, Qumseya BJ, O’Dwyer LC, Wani S. Association between endoscopist and center endoscopic retrograde cholangiopancreatography volume with procedure success and adverse outcomes: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15:1866-1875.e3.
doi: 10.1016/j.cgh.2017.06.002
pubmed: 28606848
Wani S, Han S, Simon V, Hall M, Early D, Aagaard E et al. Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees. Gastrointest Endosc. 2019;89:1160-1168.e9.
doi: 10.1016/j.gie.2019.01.030
pubmed: 30738985
pmcid: 6527477
Kedia P. Seven years later: do we still have an EDGE? Endoscopy. 2022;54:62–63.
doi: 10.1055/a-1453-0606
pubmed: 34352908
Nylund K, Hausken T, Ødegaard S, Eide GE, Gilja OH. Gastrointestinal wall thickness measured with transabdominal ultrasonography and its relationship to demographic factors in healthy subjects. Ultraschall Med Eur J Ultrasound. 2012;33:E225–E232.
doi: 10.1055/s-0031-1299329
Krafft MR, Lorenze A, Croglio MP, Fang W, Baron TH, Nasr JY. “Innocent as a LAMS”: Does Spontaneous Fistula Closure (Secondary Intention), After EUS-Directed Transgastric ERCP (EDGE) via 20-mm Lumen-Apposing Metal Stent, Confer an Increased Risk of Persistent Fistula and Unintentional Weight Gain? Dig Dis Sci. 2021;
Krafft MR, Fang W, Nasr JY. Shortened-interval dual-session EDGE reduces the risk of LAMS dislodgement while facilitating timely ERCP. Dig Dis Sci 2021;66:2776–2785.
doi: 10.1007/s10620-020-06551-5
pubmed: 32816212
Khan MA, Kedia P, Tyberg A, Shrestha S, Ismail MK, Gaidhane M et al. Mo1338 Comparison of EUS directed transgastric endoscopic retrograde cholangiopancreatography (EDGE) with laparoscopic guided endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y Bypass: a meta-analysis. Gastrointest Endosc. 2018;87:AB452–AB453.
doi: 10.1016/j.gie.2018.04.1988
Wang TJ, Cortes P, Jirapinyo P, Thompson CC, Ryou M. A comparison of clinical outcomes and cost utility among laparoscopy, enteroscopy, and temporary gastric access-assisted ERCP in patients with Roux-en-Y gastric bypass anatomy. Surg Endosc 2021;35:4469–4477.
doi: 10.1007/s00464-020-07952-3
pubmed: 32886240
James HJ, James TW, Wheeler SB, Spencer JC, Baron TH. Cost-effectiveness of endoscopic ultrasound-directed transgastric ERCP compared with device-assisted and laparoscopic-assisted ERCP in patients with Roux-en-Y anatomy. Endoscopy. 2019;51:1051–1058.
doi: 10.1055/a-0938-3918
pubmed: 31242509
Abu Dayyeh BK, Thompson CC, Gostout C. Endoscopic retrograde cholangiopancreatography after Roux-en-Y gastric bypass: challenges and cautions. Gastroenterology. 2015;148:858–859.
doi: 10.1053/j.gastro.2014.11.051
pubmed: 25726737
Diehl DL, Gabrielsen JD, Strodel WE. The challenges of endoscopic retrograde cholangiopancreatography in gastric bypass patients: the game is not yet over. Gastroenterology. 2015;148:857–858.
doi: 10.1053/j.gastro.2014.11.052
pubmed: 25726746
Tyberg A, Kedia P, Tawadros A, Tarnasky PR, Gaidhane M, Nieto J et al. EUS-directed transgastric endoscopic retrograde cholangiopancreatography (EDGE): the first learning curve. J Clin Gastroenterol. 2020;54:569–572.
doi: 10.1097/MCG.0000000000001326
pubmed: 32149820